Palmetto Retina Center | West Columbia, SC
Status and phase
Conditions
Treatments
About
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Macular Edema (CI-DME) to Evaluate the Efficacy, Safety of the Port Delivery System with Ranibizumab (PDS) Relative to the Comparator Arm
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion Criteria for Study Eye
Exclusion criteria
Ocular Exclusion Criteria for Study Eye:
Ocular Exclusion Criteria for Either Eye
Primary purpose
Allocation
Interventional model
Masking
174 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal